Cargando…

389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children

BACKGROUND: During the earlier phase of the COVID-19 pandemic, published reports demonstrated low rates of COVID co-viral infections. Upon relaxing public health measures, the epidemiology of known respiratory viral pathogens had dramatically shifted as the pandemic evolved. Little is known about th...

Descripción completa

Detalles Bibliográficos
Autores principales: Anosike, Brenda I, Sharma, Shiv M, Sarill, Kiera, Alrikaby, Jassour, Duong, Tim Q, Herold, Betsy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678413/
http://dx.doi.org/10.1093/ofid/ofad500.459
_version_ 1785150355574620160
author Anosike, Brenda I
Sharma, Shiv M
Sarill, Kiera
Alrikaby, Jassour
Duong, Tim Q
Herold, Betsy
author_facet Anosike, Brenda I
Sharma, Shiv M
Sarill, Kiera
Alrikaby, Jassour
Duong, Tim Q
Herold, Betsy
author_sort Anosike, Brenda I
collection PubMed
description BACKGROUND: During the earlier phase of the COVID-19 pandemic, published reports demonstrated low rates of COVID co-viral infections. Upon relaxing public health measures, the epidemiology of known respiratory viral pathogens had dramatically shifted as the pandemic evolved. Little is known about the clinical impact of co-viral infections in children post-Omicron wave. This study investigates the clinical outcomes among children, adolescents, and young adults who test positive for SARS-CoV-2 [COVID] alone compared to those with COVID co-viral infection with either RSV or Influenza [Flu] A/B [denoted as COVID+] METHODS: We conducted a retrospective study of subjects ≤ 21 years of age who tested positive for SAR-CoV-2 presenting to the Children’s Hospital at Montefiore, Bronx, NY from 12/1/2021 to 1/15/2023. Laboratory confirmation was established using a multi-target PCR assay for influenza A/B, RSV, and SARS-CoV-2. The primary outcomes were hospitalization, need for invasive mechanical ventilation (IMV), and mortality. Demographic and patient outcomes were extracted using ATLAS database. RESULTS: Among 8307 subjects who tested positive for COVID alone, 8.5% (708) were hospitalized with a mean age of 8.7 years (SD=7.8) while mean age of those with COVID+ was 5.0 years (SD=4.4). Hospitalization rates for COVID alone, COVID+Flu, and COVID+RSV were 6.4%, 32.2%, and 57.7%, respectively (p< 0.001). COVID positive children ≤ 5 years of age with or without a second virus were more likely to be hospitalized than other age group (p< 0.001). When comparing COVID+Flu vs. Flu alone (32.2% vs. 4.3%, p< 0.001) or COVID+RSV vs. RSV alone (57.7% vs. 15.8%, p< 0.001), hospitalization rates were higher for those with COVID co-viral infections. No increase in mortality was observed. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This single center retrospective study demonstrates that SARS-CoV-2 coinfection with RSV or Influenza is associated with increased risk for hospitalization compared to SARS-CoV-2, RSV or influenza alone. Hospitalization rates were higher in younger children. Further studies are needed to identify the mechanisms driving the increased morbidity associated with these coinfections. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678413
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106784132023-11-27 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children Anosike, Brenda I Sharma, Shiv M Sarill, Kiera Alrikaby, Jassour Duong, Tim Q Herold, Betsy Open Forum Infect Dis Abstract BACKGROUND: During the earlier phase of the COVID-19 pandemic, published reports demonstrated low rates of COVID co-viral infections. Upon relaxing public health measures, the epidemiology of known respiratory viral pathogens had dramatically shifted as the pandemic evolved. Little is known about the clinical impact of co-viral infections in children post-Omicron wave. This study investigates the clinical outcomes among children, adolescents, and young adults who test positive for SARS-CoV-2 [COVID] alone compared to those with COVID co-viral infection with either RSV or Influenza [Flu] A/B [denoted as COVID+] METHODS: We conducted a retrospective study of subjects ≤ 21 years of age who tested positive for SAR-CoV-2 presenting to the Children’s Hospital at Montefiore, Bronx, NY from 12/1/2021 to 1/15/2023. Laboratory confirmation was established using a multi-target PCR assay for influenza A/B, RSV, and SARS-CoV-2. The primary outcomes were hospitalization, need for invasive mechanical ventilation (IMV), and mortality. Demographic and patient outcomes were extracted using ATLAS database. RESULTS: Among 8307 subjects who tested positive for COVID alone, 8.5% (708) were hospitalized with a mean age of 8.7 years (SD=7.8) while mean age of those with COVID+ was 5.0 years (SD=4.4). Hospitalization rates for COVID alone, COVID+Flu, and COVID+RSV were 6.4%, 32.2%, and 57.7%, respectively (p< 0.001). COVID positive children ≤ 5 years of age with or without a second virus were more likely to be hospitalized than other age group (p< 0.001). When comparing COVID+Flu vs. Flu alone (32.2% vs. 4.3%, p< 0.001) or COVID+RSV vs. RSV alone (57.7% vs. 15.8%, p< 0.001), hospitalization rates were higher for those with COVID co-viral infections. No increase in mortality was observed. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This single center retrospective study demonstrates that SARS-CoV-2 coinfection with RSV or Influenza is associated with increased risk for hospitalization compared to SARS-CoV-2, RSV or influenza alone. Hospitalization rates were higher in younger children. Further studies are needed to identify the mechanisms driving the increased morbidity associated with these coinfections. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678413/ http://dx.doi.org/10.1093/ofid/ofad500.459 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Anosike, Brenda I
Sharma, Shiv M
Sarill, Kiera
Alrikaby, Jassour
Duong, Tim Q
Herold, Betsy
389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
title 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
title_full 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
title_fullStr 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
title_full_unstemmed 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
title_short 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
title_sort 389. pedicoviral: clinical outcomes of covid-related co-viral infections in children
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678413/
http://dx.doi.org/10.1093/ofid/ofad500.459
work_keys_str_mv AT anosikebrendai 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren
AT sharmashivm 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren
AT sarillkiera 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren
AT alrikabyjassour 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren
AT duongtimq 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren
AT heroldbetsy 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren